Foot Process Effacement (FPE) could serve as a valuable marker for assessing the risk of disease progression across various kidney pathologies. Read more in #ASNKidney360: kidney.pub/KID0894#ASNKidney360: @ashunephro.bsky.social @sophieclaudel.bsky.social

Our article, “Cumulative Incidence of Mortality Associated with Cardiovascular–Kidney–Metabolic (CKM) Syndrome,” published in JASN @sophieclaudel.bsky.social @asnpublications.bsky.social has been selected for the “Best of ASN Journals at KidneyWeek 2025. journals.lww.com/jasn/fulltex...

Despite repeating proteinuria measurements throughout a patient with CKD's clinical course, clinicians may overlook important temporal patterns that emerge. Read more about proteinuria trajectories and risk of adverse clinical outcomes: kidney.pub/KID0849 #ASNKidney360 @ashunephro.bsky.social

Milestone release of #rstats rms package is now on CRAN with a full suite of survival analysis fitting, validation, and graphical display functions based on semiparametric models, generalizing the Cox PH model to a spectrum of models including accelerated failure time. hbiostat.org/r/rms #StatsSky

Excited to share our comprehensive review “Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations” #CardiologyClinics @sophieclaudel.bsky.social @ahascience.bsky.social @asnkidney.bsky.social kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...

Genetic Testing in Biopsy-Confirmed Kidney Disease

Cardiovascular–kidney–metabolic (CKM) syndrome stages 1 to 4 are associated with a graded risk of cardiovascular mortality in a nationally representative sample of U.S. adults. https://bit.ly/JASN0637 #ASNJASN @ashunephro.bsky.social @sophieclaudel.bsky.social

Cumulative Incidence of Mortality (CKM) syndrome stages 1 to 4 are associated with a graded risk of cardiovascular mortality in a nationally representative sample of U.S. adults. https://bit.ly/JASN0637 #ASNJASN @ashunephro.bsky.social @sophieclaudel.bsky.social

Learned quite a lot about interactions, thresholds, and synergistic effects from @ashunephro.bsky.social in this analysis of albuminuria, heart failure, and CKD progression. Our findings emphasize albuminuria as a key biomarker for CKM health. 🫘 @jaccjournals.bsky.social #NephSky

Delighted to share our study published in @jaccjournals.bsky.social led by @sophieclaudel.bsky.social. We demonstrated deleterious synergy between albuminuria and heart failure as risk factors for CKD progression. www.jacc.org/doi/10.1016/...

Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review ca. 2025 #Nephpearls #NephSky 👉🏼 pubmed.ncbi.nlm.nih.gov/40063723/

Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review 👩‍🔬🥼🧪👨‍🔬 #CardioSky #NephSky #cardiovascular #cardio-renal #metabolicdisorder #KidneyResearch #kidneydisease 👇👇👇 www.ahajournals.org/doi/epub/10....

Extremely grateful to @ahascience.bsky.social and @ashunephro.bsky.social for the opportunity to publish this comprehensive review on albuminuria in #Circulation. We cover albuminuria in the spectrum of #CKM disorders. Please take a look! @nephjc.bsky.social #NephSky

Thank you for highlighting our review!!!

Thrilled to share our state of art review led by extraordinary @sophieclaudel.bsky.social “Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review" www.ahajournals.org/eprint/SXXGK... @ahascience.bsky.social @ahajournals.bsky.social @asnkidney.bsky.social

Excited to share this research letter looking at albuminuria values in healthy adults! We followed IFCC guidelines for establishing references ranges, which had not previously been shown in the literature, and consider what “normal” should be by sex.

We sought to quantify the upper limit of normal for albuminuria among US adults by the IFCC standard. Our study led by @sophieclaudel.bsky.social “Albuminuria References Ranges in Healthy US Adults” academic.oup.com/jalm/advance...

Thrilled to share our publication led by exceptional @sophieclaudel.bsky.social "Cumulative Incidence of Mortality Associated with Cardiovascular-Kidney-Metabolic Syndrome" in @asnpublications.bsky.social journals.lww.com/jasn/abstrac... @asnkidney.bsky.social @americanheart.bsky.social

Our comprehensive review on “ Diuretics in patients with chronic kidney disease” @natrevneph.bsky.social

Adults with higher levels of albuminuria within the low range (UACR <30 mg/g) and no major cardiovascular risk factors have higher risks of cardiovascular and all-cause mortality. academic.oup.com/eurjpc/artic... @sophieclaudel.bsky.social

Very excited to share this work by my mentor Dr. Ashish Verma and me on #SDOH and #mortality among adults *without* major chronic diseases published in @JGIM! We looked at food insecurity, employment, income, acculturation, education and healthcare access. link.springer.com/article/10.1...